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Friedreich’s ataxia (FRDA) is the most important recessive ataxia in the Caucasian
population. It is caused by a deficit of the mitochondrial protein frataxin. Despite
its pivotal effect on biosynthesis of iron-sulfur clusters and mitochondrial energy
production, little is known about the influence of frataxin depletion on homeostasis
of the cellular mitochondrial network. We have carried out a forward genetic screen
to analyze genetic interactions between genes controlling mitochondrial homeostasis
and Drosophila frataxin. Our screen has identified silencing of Drosophila mitofusin
(Marf ) as a suppressor of FRDA phenotypes in glia. Drosophila Marf is known to play
crucial roles in mitochondrial fusion, mitochondrial degradation and in the interface
between mitochondria and endoplasmic reticulum (ER). Thus, we have analyzed
the effects of frataxin knockdown on mitochondrial morphology, mitophagy and ER
function in our fly FRDA model using different histological and molecular markers such
as tetramethylrhodamine, ethyl ester (TMRE), mitochondria-targeted GFP (mitoGFP),
p62, ATG8a, LAMP1, Xbp1 and BiP/GRP78. Furthermore, we have generated the
first Drosophila transgenic line containing the mtRosella construct under the UAS
control to study the progression of the mitophagy process in vivo. Our results
indicated that frataxin-deficiency had a small impact on mitochondrial morphology but
enhanced mitochondrial clearance and altered the ER stress response in Drosophila.
Remarkably, we demonstrate that downregulation of Marf suppresses ER stress in
frataxin-deficient cells and this is sufficient to improve locomotor dysfunction, brain
degeneration and lipid dyshomeostasis in our FRDA model. In agreement, chemical
reduction of ER stress by means of two different compounds was sufficient to
ameliorate the effects of frataxin deficiency in three different fly FRDA models. Altogether,
our results strongly suggest that the protection mediated by Marf knockdown in
Abbreviations: ATF6, activating transcription factor 6; DRG, dorsal root ganglia; DRP1, dynamin-related protein 1;
eIF2α, α subunit of eukaryotic translation initiation factor 2; ER, endoplasmic reticulum; FLP/FRT, Flippase/Flippase
Recognition Target; FRDA, Friedreich’s ataxia; GGCs, giant glial cells; IFM, Indirect Flight Muscles; IRE1, inositol-requiring
enzyme 1; MAMs, mitochondria-associated membranes; mitoGFP, mitochondria-targeted GFP; OPA1, optic atrophy 1;
PBA, 4-phenylbutyric acid; PERK, pancreatic ER kinase; TUDCA, tauroursodeoxycholic acid; TMRE, tetramethylrhodamine,
ethyl ester; UPR, unfolded protein response.
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glia is mainly linked to its role in the mitochondrial-ER tethering and not to mitochondrial
dynamics or mitochondrial degradation and that ER stress is a novel and pivotal player
in the progression and etiology of FRDA. This work might define a new pathological
mechanism in FRDA, linking mitochondrial dysfunction due to frataxin deficiency and
mitofusin-mediated ER stress, which might be responsible for characteristic cellular
features of the disease and also suggests ER stress as a therapeutic target.
Keywords: Friedreich’s ataxia, Drosophila melanogaster, mitofusin, ER stress, glia, mitophagy, muscles,
mtRosella
INTRODUCTION
Friedreich’s ataxia (FRDA) is the most common autosomal
recessive ataxia in the Caucasian population (Cossée et al.,
1997). The presence of a pathological GAA expansion in the
first intron of the human FXN locus impairs the correct
transcription of the gene, leading to low levels of the protein
frataxin and causing the disease (Campuzano et al., 1997). The
function of frataxin as a cardinal regulator of the biosynthesis
of iron-sulfur clusters seems to be well established (Tsai
and Barondeau, 2010; Schmucker et al., 2011). However,
recent studies have questioned this role (Moreno-Cermeño
et al., 2013) and thus frataxin’s function is still a subject of
controversy. Nevertheless, it has been demonstrated that reduced
frataxin expression compromises the activity of iron-sulfur
cluster-containing enzymes along with mitochondrial ATP
production and mitochondrial membrane potential (Rötig et al.,
1997; Lodi et al., 1999; Tan et al., 2001; Anderson et al.,
2005; Shidara and Hollenbeck, 2010; Bolinches-Amorós et al.,
2014).
The neurological pathology in FRDA is very prominent.
Indeed, patients display several neurological phenotypes such
as progressive degeneration of dorsal root ganglia (DRG),
lesions in the dentate nucleus and corticospinal tracks as well
as an atrophy of the peripheral nerves and a ‘‘dying back’’
neuropathy (reviewed in Koeppen and Mazurkiewicz, 2013).
Although changes in other cell types are considered secondary,
it is important to remark that tissues with an abundant
expression of frataxin such as glial cells and skeletal muscles
also display pathological manifestations. In this sense, a drastic
demyelination of the large axons has also been reported in
patients (Hughes et al., 1968; Koeppen et al., 2009; Koeppen
and Mazurkiewicz, 2013; Corben et al., 2014), suggesting a
critical dysfunction of Schwann cells. Strong loss of myelin,
consistent with axonal defects, has also been described in
rodent models (Simon et al., 2004; Al-Mahdawi et al., 2006).
Similarly, targeted silencing of frataxin expression in glial
cells in Drosophila melanogaster highlighted defects on lipid
metabolism, oxidative stress and tissue integrity (Navarro et al.,
2010). Moreover, frataxin depletion in different glial cell types
resulted in a significant decrease in viability and proliferation,
along with a boost of mitochondrial superoxide production,
the activation of inflammatory and apoptotic responses and
impairment of neuron-glia interactions (Lu et al., 2009; Loría
and Díaz-Nido, 2015). Besides nervous system dysfunction,
FRDA patients show a chronic myocarditis and a severe
hypertropy of the myocardium (Russell, 1946; Weidemann
et al., 2013; Koeppen et al., 2015) as well as progressive and
symmetrical loss of muscle strength particularly affecting the
lower limbs (Beauchamp et al., 1995). Magnetic resonance
spectroscopy of the calf muscles in FRDA patients demonstrates
impairment of ATP synthesis, inadequate oxygen utilization by
muscles and prolonged recovery after exercise (Lynch et al.,
2002; Nachbauer et al., 2012). In contrast, conditional ablation
of frataxin in mouse muscles induces cardiac hypertrophy
without relevant defects in skeletal muscles (Puccio et al.,
2001).
Mitochondria are dynamic organelles that, depending
on the physiological conditions, constantly undergo fusion
and fission steps to supply the cell with ATP from oxidative
phosphorylation (reviewed in Westermann, 2010, 2012).
Therefore, it is reasonable to speculate that the mitochondrial
dysfunction induced by RNAi mediated knockdown of frataxin
would also affect the intracellular mitochondrial network
altering the number, size and morphology of mitochondria,
maybe further contributing to the pathogenesis of the disease.
Indeed, it has been reported that frataxin knockdown in
mammalian cells triggers the formation of giant or larger
disorganized mitochondria in rodent muscles (Puccio et al.,
2001) or in cultured cells (Calmels et al., 2009; Hick et al.,
2013; Bolinches-Amorós et al., 2014; Obis et al., 2014). Other
studies have also shown accumulation or hyperproliferation of
mitochondria in mouse and cellular models (Payne et al.,
2011; Hick et al., 2013, respectively). On the contrary,
some reports have described increased mitochondrial
fragmentation instead (Lefevre et al., 2012; Schiavi et al.,
2015).
Notably, disruption of mitochondrial fusion and fission and
mitochondrial quality control impairs normal distribution of
mitochondria and in turn the local ATP production. This
might be especially critical in neurons as they require large
amounts of energy and depend mainly on mitochondrial
respiration. Indeed, imbalance of mitochondrial dynamics
has emerged as a common pathogenic element to several
neurodegenerative diseases such as Parkinson’s disease, Charcot-
Marie-Tooth, Alzheimer’s disease, Huntington’s disease or
amyotrophic lateral sclerosis (reviewed in Reddy, 2014). In
agreement, mitochondrial dynamics has been suggested as a
possible target for therapeutic intervention in neurodegenerative
disorders (Reddy, 2014; Civiletto et al., 2015). In the current
working model of mitochondrial homeostasis, damaged or
senescent mitochondria are detected when their inner membrane
depolarizes. The decay in membrane potential activates a
cellular pathway controlled by the Pink1 kinase and the
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ubiquitin-ligase Parkin that will modify the mitochondrial
network by promoting the fusion of healthy mitochondria and
the fission of inactive organelles prior to their degradation
by mitophagy (reviewed in Westermann, 2010). This dynamic
regulation, critical to mitochondrial function, relies on a core
machinery formed by a group of GTPases named mitofusin
(MFN1 and 2), optic atrophy 1 (OPA1) and dynamin-related
protein 1 (DRP1) as well as on the mitochondrial quality control
genes Pink1 and Parkin. The damaged organelles are finally
degraded by macroautophagy in a process named mitophagy
(Westermann, 2012). In recent years, several exciting studies
have shown that the regulation of mitochondrial homeostasis
is conserved in the fruit fly and that Drosophila is an excellent
and pioneer model to analyze the leading role of mitochondrial
dynamics in relation to neurodegenerative disorders (Corti
et al., 2011). Most of the compelling evidences in the fruit fly
regarding mitochondrial dynamics have come from studies in
Drosophila adult indirect flight musculature and in dopaminergic
neurons (Greene et al., 2003; Clark et al., 2006; Yang et al.,
2006; Deng et al., 2008). Similarly, the core elements of
mitophagy are also present in Drosophila (Vincow et al.,
2013).
Despite the severe impact of frataxin depletion on
mitochondria biology, to present, only two studies have
addressed the impact of frataxin silencing on the homeostasis
of the cellular mitochondrial network (Lefevre et al., 2012;
Schiavi et al., 2015). Interestingly, frataxin silencing has also been
reported to increase the expression or activity of endoplasmic
reticulum (ER) stress markers (Cortopassi et al., 2006; Lu and
Cortopassi, 2007; Huang et al., 2013) or to sensitize cells to
chemically-induced ER stress (Cnop et al., 2012; Bolinches-
Amorós et al., 2014). However, no direct mechanism linking
ER with the pathology has yet been described in FRDA disease
models.
In this work, we report the first genetic screen designed
to analyze the influence of mitochondrial dynamics on FRDA
phenotypes. Our results show that downregulation of Mitofusin
is sufficient to rescue several defects triggered by frataxin
deficiency in glia. Mitofusin has been shown to be involved
in mitochondrial dynamics and mitochondrial-ER tethering in
Drosophila. Our experiments dissecting the roles of Mitofusin in
the fly FRDA model provide evidence that: (1) frataxin silencing
induces accumulation of Drosophila p62 in muscles and glial
cells; (2) the cellular machinery is able to detect the dysfunctional
mitochondria and activates mitophagy for clearance of the
damaged organelles; (3) the enhanced mitophagic flux is
not sufficient to degrade the massive amount of affected
mitochondria and this might trigger the accumulation of
inefficient organelles and of autophagy markers; (4) additional
activation of autophagy also might be beneficial; (5) frataxin
knockdown enhances ER stress; (6) Mitofusin modulates the
ER stress in frataxin-deficient glia and chemical reduction of
ER stress improves several phenotypes in FRDA flies; and
(7) for the first time in any FRDA model, we have been
able to show that mitochondrial dysfunction and ER stress
represent a crucial convergence point in the pathology of the
disease.
MATERIALS AND METHODS
Drosophila Stocks
Fly stocks were maintained at 25◦C on standard cornmeal-agar
medium (water: 36 l; yeast: 720 g; cornmeal: 3200 g; soy flour:
400 g; light malt extract: 3200 g; sugar beet syrup: 880 g; agar:
320 g, Nipagin 120 g). The crosses between the GAL4 drivers
and the UAS responder lines were carried out at 25◦C unless
stated. UAS constructs were used in heterozygous configurations
for all experiments. The stocks used in this work as well as their
origin are listed in Table S1 of Datasheet 1 in the Supplementary
Material. Genetic interactions were carried out by first generating
the stocks fhRNAi-1/CyO; Repo-GAL4/TM6B tub-GAL80 and
fhRNAi-1/CyO;Mef2-GAL4/TM6B tub-GAL80.
Generation of mtRosella Transgenic Flies
cDNA for the mtRosella construct was kindly provided by
Prof. Dr. Benedikt Westermann (Böckler and Westermann,
2014). A 1700 bp fragment was amplified using the primers
mtRosellaFw (CTCGAGATGTGGACTCTCGGGCGCCG)
and mtRosellaRv (GGTACCTCAAGCATCTTTTCCGGAAT
AGGCCAAG). The full length coding sequence of mtRosella
was cloned into the Gatewayr entry vector pENTR/D-
TOPOr by BP-cloning (Invitrogen, Carlsbad, CA, USA)
and was subcloned by LR-cloning (Invitrogen, Carlsbad,
CA, USA) into PWH-attB plasmid vector (modified from
PWH obtained from the Drosophila genomics Resource
Center and kindly provided by Prof. Michael Krahn)
generating the transgene UAS-mtRosella-PWH. The
transgene was then integrated into the third chromosome
of the Drosophila genome using the PhiC31 integrating
cassette. Three independent lines were obtained for the
construct.
Real-Time PCR
Total RNAwas extracted from 15 thoraces using peqGold TriFast
reagent (PEQLAB Biotechnologie GMBH, Erlangen, Germany)
following manufacturer’s instructions. Five-hundred nanogram
mRNA were converted into cDNA using QuantiTect Rev.
Transcription Kit (Qiagen GmbH, Hilden, Germany) and then
used for qPCR with ORA qPCR Green ROX L Mix (HighQu,
Kralchtal, Germany) on a CFX connectTM Real-Time PCR
Detection System (Bio-rad, Hercules, CA, USA). The ribosomal
protein 49 (rp49) was used as internal control. The results from
at least four independent biological replicates were analyzed with
the Bio-Rad CFX manager 3.1 software. Gene expression levels
were referred to the internal control, the relative quantification
was carried out by means of the ∆∆Ct method and the results
were plotted as relative mRNA expression. Each experiment
consisted of 3–5 independent biological replicates. The genes and
the pairs of primers used for the analysis are summarized in Table
S2 of Datasheet 1 in the Supplementary Material.
Analysis of Mitochondrial DNA (mtDNA)
Levels
For DNA extraction, thoraces from 15 to 20 male flies
of desired age were homogenized in 400 µl Buffer A
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(100 mM Tris, pH7.5, 100 mM EDTA, 100 mM NaCl, 0.5%
SDS). After incubation at 65◦C for 60 min with continuous
shaking, 800 µl of LiCl/KAc (5 M KAc and 6 M LiCl in
a relation 1:2.5) solution were added, followed by 10 min
incubation on ice. After centrifugation (15 min, 13,000 rpm,
RT), 1 ml supernatant was transferred in a new tube. The
DNA was precipitated by adding 600 µl of isopropanole
and vortexing. After centrifugation (15 min, 13,000 rpm,
RT) the resulting pellet was washed with 70% ethanol and
resuspended in 200 µl H2O. Isolated DNA was quantified
by measuring the absorbance at 260 nm with a NanoDrop
spectrophotometer (PEQLAB Biotechnologie GMBH, Erlangen,
Germany) and frozen at −20◦C. In order to estimate the
amount of mtDNA, the levels of mitochondrial cytochrome
oxidase I (Fw 5′-AACTGTTTACCCACCTTTATCTGCTB-3′
and Rv 5′-CCCGCTAAGTGTAAAGAAAAAATAGC-3′) were
referred to the levels of the housekeeping gene GAPDH (Fw
5′-GACGAAATCAAGGCTAAGGTCG-3′ and Rv 5′-AATGGG
TGTCGCTGAAGAAGTC-3′), using 10 ng of Template DNA
per reaction. Reactions were performed with qPCR Green ROX
L Mix (HighQu, Kralchtal, Germany) on a CFX connectTM
Real-Time PCR Detection System (Bio-rad, Hercules, CA,
USA). The relative quantification was carried out by means
of the ∆∆Ct method and the results were plotted as Relative
mtDNA content. Each experiment consisted of 3–5 independent
biological replicates.
Western Blot
For Western blots, 15 larvae (L2 and L3), adult male flies
or thoraces were homogenized in 80 µl cold RIPA buffer
(Sigma-Aldrich, St. Louis, MO, USA) with complete protease
inhibitor mixture (Roche, Mannheim, Germany). The protein
levels were determined using the BCA protein quantification
kit (Thermo Scientific, Schwerte, Germany). Samples were
diluted 1:4 with standard 4× Laemmli buffer, boiled for
5 min and approximately 25–30 µg of proteins were separated
on 5% stacking-10% separating SDS polyacrylamide gels.
The resolved proteins were electroblotted to a Protran BA
85 nitrocellulose membrane (Hartenstein, Würzburg, Germany)
and were probed using rabbit anti-p62 (1:3000, kindly provided
by Gábor Juhász, Pircs et al., 2012), rabbit anti-phospho
eIF2αS1 (1:1500, ab32157, abcam, Cambridge, UK) and rabbit
anti-GFP (1:2500, A6455, Invitrogen, Carlsbad, CA, USA).
Mouse anti-α-tubulin (1:5000, T9026, Sigma-Aldrich, St. Louis,
MO, USA) and rabbit anti-actin (1:2500, Sigma-Aldrich,
St. Louis, MO, USA) were used as loading controls. Secondary
fluorescent goat anti-mouse 680 LT and goat anti-Rabbit
800 CW (1:10,000 and 1:5000 respectively, Li-Cor Inc., Bad
Homburg, Germany) were used in all cases. Detection and
quantification was conducted using the Odyssey system (Li-
Cor Inc., Lincoln, NE, USA). Arbitrary fluorescent units were
normalized to the internal loading control. Data were expressed
as percentage of average control values and plotted as relative
protein levels. At least three independent biological replicates
were used for each genotype and condition. The original
images of representative blots shown or quantified in this
manuscript highlighting the area displayed in the corresponding
figures are available in the Datasheet 2 in the Supplementary
Material.
Brain and Muscle Histology
Flies of appropriate age and genotype were fixed in 4% PFA
for 2 h. Brains or thoraces were then dissected, washed with
PBST and blocked with 10% Normal Goat Serum or 10%
Normal Donkey Serum, depending on secondary antibody,
and incubated 24 h at 4◦C with the primary antibody: mouse
anti-Repo (1:200, 8D12, Developmental Studies Hybridoma
Bank, Iowa city, IA, USA), goat anti-GFP (1:100, 600-101-215,
Rockland, PA, USA), rabbit anti-p62 (1:500, kindly provided
by Sébastien Gaumer, Nezis et al., 2008) and rat anti-BiP
(1:200, BT-GB-143P, Babraham Bioscience Technologies,
Cambridge, UK). Then, samples were incubated 24 h at 4◦C
with secondary fluorescent antibodies: donkey anti-goat AF488,
donkey anti-rabbit AF594, donkey anti-mouse AF555, goat
anti-rabbit AF488, goat anti-rat AF555 (in all cases 1:200,
Invitrogen, Carlsbad, CA, USA), goat anti-mouse Cy3 (1:200,
Jackson Dianova, Hamburg, Germany), DAPI (10 µg/ml,
Sigma-Aldrich, St. Louis, MO, USA) and TRITC-conjugated
Phalloidin to visualize F-actin from muscle fibers (1:500,
Sigma-Aldrich, St. Louis, MO, USA). Samples were embedded
in Vectashield mounting medium (Vector Laboratories,
Burlingame, CA, USA). At least 5–10 flies per genotype
were scanned. GFP and antibody patterns were analyzed
by scanning the samples using the multi-tracking setups of
either a LSM 510 Confocal Microscope (Zeiss, Germany)
or Confocal Laser Scanning Platform Leica TSC SP8 (Leica,
Germany).
In order to analyze mitochondrial membrane potential in
indirect flight muscles (IFM), flies were anesthetized with CO2
and the head, abdomen, wings and legs were removed. The
thorax was cut sagitally with a sharp injector blade (Stainless
Steel Injector Blades, Cat. #71990, Electron Microscopy Sciences,
Hatfield, PA, USA). The hemithoraces were then incubated with
1 µm tetramethylrhodamine, ethyl ester (TMRE; Cat. #89917,
Sigma-Aldrich, Germany) in Relaxing solution (20mMKH2PO4,
5 mMMgCl2, 5 mM EGTA, 5 mMATP) for 15 min, washed with
Relaxing Solution three times for 5 min, mounted in VectaShield
and immediately imaged.
All images were acquired using the same exposure, light
intensity and filter settings for all conditions. Confocal images
were further processed with the image processing software
Fiji 2.0.0 (Schindelin et al., 2012). In detail, background
was subtracted in ImageJ via the ‘‘Rolling Ball’’ method
(Radius = 50 pixels). Maximum projections of three (muscle
images) to 30 (brain images) slices were made and the resulting
image was again subjected to background subtraction. Finally,
contrast of each image was adjusted to improve quality of signal.
Further details about confocal microscope settings and image
handling are described in the Supplementary methods.
Paraffin sections were performed from 35-day-old adult flies.
Flies were fixed with carnoy (ethanol:chloroform:acetic acid
at a proportion 6:3:1), dehydrated in ethanol, and embedded
in paraffin. Paraffin sections (7 µm) from 10 flies of each
genotype were analyzed under a fluorescence microscope. Brain
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vacuolization was quantified using the ImageJ 1.48v software.
The affected area was referred as % of total brain area that
includes the lamina (La), the outer chiasm (OC) and the
medulla (Me). For examination of lipid accumulation with
light microscopy and analysis of degeneration of photoreceptor
neurons, semithin epon plastic sections from 35-day-old
and 5-day-old adult fly brains, respectively, were prepared.
Lipids were identified by characteristically dark droplet-like
structures.
Aconitase Activity and ATP Quantity
Total aconitase activity was determined from whole individuals
using Bioxytech Aconitase-340TM Spectrophotometric Assay
kit (OXIS International Inc., Portland, OR, USA). Twenty-
five adults or 15 thoraces were placed in a tube containing
500 µl of ice-cold homogenization buffer (0.2 mM sodium
citrate and 50 mM Tris-HCl, pH 7.4) and gently pounded. The
resulting mashes were centrifuged twice at 800 g for 10 min
at 4◦C discarding the pellet every time. Supernatants were
disrupted by sonication for 30 s with 1 s interval between each
pulse. One-hundred microliter of each extraction was used to
measure the aconitase activity. The aconitase activity of each
genotype was measured from four independent samples and each
extraction was measured twice. The aconitase activity was finally
referred to protein amount using the Bradford assay (Coomassie
PlusTM Protein Assay Reagent, Thermo Scientific, Schwerte,
Germany). ATP was determined using ATP Bioluminescence
Assay Kit CLS II (Roche, Mannheim, Germany) according to
manufacturer’s instructions with some modifications. Briefly,
five thoraces were homogenized in 200 µl pre-heated ATP
assay buffer (100 mM Tris, 4 mM EDTA, pH 7.75), boiled for
2 min and centrifuged for 1 min at 1000 g. The supernatant
was diluted 1:3 in ATP assay buffer and 50 µl of the dilution
were used to measure ATP levels. Luminescence was detected
with a Tecan Infiniter F500 plate reader (Tecan Trading AG,
Switzerland). Each experiment consisted of 3–5 independent
biological replicates.
Lifespan, Chemical Treatments, Hyperoxia
and Negative Geotaxis Assays
In all experiments (normal conditions and food
supplementation), flies were raised at 25◦C under a 12 h:12 h
light/dark cycle and male individuals were collected within
24–48 h posteclosion, placed at a density of 25 per vial and
transferred to vials with the corresponding fresh food every
2–3 days. Lifespan experiments were conducted in standard
cornmeal agar medium and 100–150 males per genotype were
used in each experiment. For chemical treatments, Instant
Drosophila Medium (Formula 4–24, Carolina Biological,
Whitsett, NC, USA) was rehydrated either with 15 mM
Tauroursodeoxycholic acid (TUDCA, Merck Miilipore, MA,
USA), 7.5 mM 4-Phenylbutyric acid (4-PBA, Sigma-Aldrich,
St. Louis, MO, USA) or 50 µm Rapamycin (LC Laboratories,
Woburn, MA, USA). As control treatment, Instant Drosophila
Medium was reconstituted with distilled water or DMSO
diluted in distilled water. Hyperoxia treatment started 1 day
post-eclosion and was performed by exposing flies in a glass
container with a constant flux of 99.5% oxygen under a low
positive pressure at 25◦C (Botella et al., 2004). Flies were
transferred every day to new vials. Locomotor assays were
performed as previously described (Botella et al., 2004). Ten to
twelve flies per genotype were assessed and each fly was recorded
three times and the mean value of each fly was used for the
subsequent analysis.
Statistical Analysis
Survival data were analyzed using the Log-rank (Mantel-Cox)
and Gehan-Breslow-Wilcoxon tests. In all further experiments,
data is represented as mean ± SEM of 4–5 replicates. When
comparing two samples, equal variances were confirmed by an
F test. When comparing multiple samples, equal variances were
confirmed by Bartlett and Brown-Forsythe tests. Normality of
data was assessed in all cases with Shapiro and Wilk test and
parametric or non-parametric tests were used accordingly. For
data that passed normality test, significance was determined
by two-tailed T-test or by One-way ANOVA with post hoc
Dunnett or Tukey Multiple Comparison Test (∗∗∗P < 0.001;
∗∗P < 0.01 and ∗P < 0.05). Statistical analysis was carried out
using Prism version 7.02 for Windows, GraphPad Software, La
Jolla, CA, USA1.
Preparation of Figures
All figures were assembled with Adobe Photoshop CC 2017.0.0
(Adobe Systems) by importing microscopy images from Fiji and
graphs from Prism.
RESULTS
Mitofusin Downregulation Rescues FRDA
Glial Phenotypes
Downstream effects of frataxin downregulation such as altered
transport, number, size and morphology of mitochondria
(Puccio et al., 2001; Calmels et al., 2009; Shidara and Hollenbeck,
2010; Chen et al., 2016b) indicate defects in the stability, integrity
and homeostasis of this organelle that might be contributing
to the pathobiology of FRDA. However, the impact of
mitochondrial dynamics on frataxin downregulation phenotypes
has never been studied. This encouraged us to further investigate
whether genetic manipulation of mitochondrial homeostasis
might also provide beneficial effects in frataxin-deficient flies.
We have reported previously that frataxin knockdown in
glia affects fly locomotion, increases brain vacuolization due
to cellular degeneration and triggers accumulation of lipids
(Navarro et al., 2010). We now first assessed whether altered
expression of genes involved in mitochondrial homeostasis
had any influence on the locomotor performance of frataxin-
deficient flies. Thus, fhRNAi-1/CyO; Repo-GAL4/TM6B Tub-
GAL80 flies (Navarro et al., 2015) were mated with a collection
of fly lines to increase or downregulate the expression of
genes involved in mitochondrial fusion and fission (Marf,
Opa1 and Drp1), mitochondrial quality control (Pink1 and
1www.graphpad.com
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FIGURE 1 | Mitofusin silencing improves locomotor ability, brain vacuolization and lipid accumulation in frataxin-deficient glial cells. (A) Negative geotaxis
performance of 10-day-old flies displaying glial-specific frataxin silencing and coexpression of our transgene’s collection. (B–E) Representative brains from
35-day-old flies displaying frataxin knockdown in glial cells and (fhRNAi-1; Repo-GAL4) along with coexpression of (B) UAS-mcherryRNAi. A second transgene does
not modify brain vacuolization and thus no GAL4 dilution effect is present, (C) UAS-MarfRNAi. Complete rescue of brain vacuolization and (D) UAS-Marf.
Overexpression of Marf (MarfOE) results in a more severe brain vacuolization. (E) UAS-MarfRNAi (TRiP). A second RNAi line for Marf shows the same effect. (F) Wild
type brain displaying the area of study (dotted white line) consisting of medulla, lamina and outer chiasm (OC). Quantification of degenerated area (%) in 35-day-old
flies. Control flies show only minor vacuolization (1.3%) of the analyzed area. Frataxin deficiency increased the degeneration by five-fold which was suppressed by
both Marf downregulations. Marf overexpression further enhanced the vacuolization. (G) Representative semithin plastic epon section of a 35-day-old control fly
(Repo-GAL4/UAS-mcherryRNAi). No lipid accumulation and brain vacuolization was detected. (H) Representative semithin plastic epon section of a 35-day-old
frataxin-deficient fly coexpressing a neutral transgene (fhRNAi-1/+; Repo-GAL4/UAS-mcherryRNAi). Strong lipid accumulation (arrows) and brain vacuolization
(asterisks) were detected. (I) Representative semithin plastic epon section of a frataxin-deficient fly coexpressing a transgene to downregulate Marf (fhRNAi-1/+;
Repo-GAL4/UAS-MarfRNAi). Clear reduction of the size of lipid droplets (arrows) and the number of brain vacuoles (asterisks) were observed. Graphs in (A,F) show
means ± SEM. Data was analyzed by One-way ANOVA with post hoc Dunnett Multiple Comparison Test. ∗P < 0.05; ∗∗∗P < 0.001. In all images, scale bar
represents 50 µm.
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FIGURE 2 | Targeted silencing of frataxin in glia alters mitochondrial homeostasis. (A) Representative optic lobe of a 35-day-old control fly (UAS-mitoGFP/+;
Repo-GAL4/UAS-mcherryRNAi) stained with mitochondria-targeted GFP (mitoGFP) and the glial specific marker Repo. (B) Magnification of the giant glial cells
(GGCs) in the inner optic chiasm from (A; white square). Mitochondria are broadly distributed. (C) Representative optic lobe of a 35-day-old Friedreich’s ataxia
(FRDA) fly (UAS-mitoGFP/+; Repo-GAL4/fhRNAi-1). (D) Magnification of the GGCs in the inner optic chiasm from (C;white square). No evident alteration of
mitochondrial distribution. (E) Optic lobe of a 35-day-old control stained with p62 antibody (UAS-mitoGFP/+; Repo-GAL4/UAS-mcherryRNAi). Presence of
p62-positive signals throughout the brain due to the aging process (Nezis et al., 2008) without any accumulation in the inner optic chiasm. (F) Optic lobe of a
35-day-old FRDA fly (UAS-mitoGFP/+; Repo-GAL4/fhRNAi-1) stained with p62. Strong accumulation of p62 in the GGC cells (denoted area). (G) Western blot
analysis of p62 levels in whole heads of control and frataxin deficient flies. No significant accumulation was detected. (H) Number of GGCs in control (UAS-nGFP/+;
Repo-GAL4/UAS-mcherryRNAi) and frataxin-deficient (UAS-nGFP/+; Repo-GAL4/fhRNAi-1) flies. Only cells displaying nuclear GFP signal and repo immunoreactivity
were used for quantification. No loss of cells was detected upon frataxin-silencing. Scale bars in (A,C,E,F) represent 40 µm and 10 µm for (B,D). Graphs in (G,H)
show means ± SEM. Statistical analysis was performed by two-tailed T-test (G) or one-way ANOVA with post hoc Dunnett Multiple Comparison test (H).
Parkin) and mitochondrial biogenesis (Spargel, Srl). We decided
to add a second group of genes involved in mitochondrial
motility (Miro, Milton and Khc) since they have been shown
to be important for glial function (Schmidt et al., 2012).
Due to the known positive effects of antioxidant genes in
FRDA flies (Anderson et al., 2008; Navarro et al., 2010),
we also included in our analysis a constitutively expressed
mitochondrial catalase (mitocatalase) construct as a secondary
control of the reliability of our strategy. As expected, frataxin-
deficient flies in glia showed reduced climbing ability (0.8 cm/s)
compared to controls (1.5 cm/s). Importantly, coexpression of
two neutral transgenes such as UAS-GFP andUAS-mcherryRNAi
did not significantly alter the locomotion of FRDA flies. In
addition, frataxin overexpression (UAS-fh) significantly rescued
locomotor performance. As expected, expression ofmitocatalase
also ameliorated locomotor dysfunctions of frataxin-deficiency
in glial cells (1.3 cm/s). All these results support the
suitability of our experimental setup to test for genetic
interactions.
Our results, summarized in Figure 1A, showed that among
all lines tested only Mitofusin (Marf ) downregulation, using an
RNAi line extensively described in the literature (Deng et al.,
2008; Dorn et al., 2011; Celardo et al., 2016), had a strong positive
impact.Marf knockdown in glial cells rescued FRDA locomotion
up to control levels (1.6 cm/s). Remarkably, compared to
frataxin-deficient flies coexpressing the mcherryRNAi transgene
(Figures 1B,H and quantification in Figure 1F), Marf silencing
also suppressed brain vacuolization (Figure 1C and asterisks
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FIGURE 3 | Frataxin silencing in muscles promotes mitochondrial fragmentation and accumulation of p62-positive structures. (A,B) MitoGFP labeled mitochondria
from 10-day-old controls (A, UAS-mitoGFP/+; Mef2-GAL4/UAS-mcherryRNAi) and from 10-day-old frataxin-deficient thoraces (B, UAS-mitoGFP/+;
Mef2-GAL4/fhRNAi-1). (B) A strong fragmentation was detected. Arrows indicate donut-like mitochondria in which the GFP signal is severely reduced as an
indication of disorganized cristae. (C) Drosophila p62 staining in 5-day-old control muscles (UAS-mitoGFP/+; Mef2-GAL4/UAS-mcherryRNAi). (D) Drosophila
p62 staining in 5-day-old frataxin-deficient muscles (UAS-mitoGFP/+; Mef2-GAL4/fhRNAi-1). Several p62 positive signals were detected. (E) Representative
example of a p62 Western blot and quantification of p62 protein levels in FRDA flies 1 day and 5 days posteclosion compared to age-matched controls. Strong
accumulation of p62 upon frataxin silencing in Drosophila muscles. Scale bar represents 10 µm in (A–D). Graph in (E) represents means ± SEM. Statistical analysis
was performed by Unpaired T-test. ∗∗P < 0.01; ∗∗∗P < 0.001.
in Figure 1I and quantification in Figure 1F) and restored
the lipid dysfunction as seen by the reduced number and
size of lipid droplets in the fly brains (arrows in Figure 1I)
with a similar aspect to controls (Figure 1G). In agreement,
Marf overexpression worsened brain degeneration (Figure 1D
and quantification in Figure 1F). A second RNAi line (TRiP)
confirmed the ability of Marf silencing to rescue locomotor
performance (Figure 1A) and the increased brain vacuolization
(Figure 1E and quantification in Figure 1F) of frataxin
deficiency.
Our results highlight Marf as a key molecule in the
neurological dysfunction in FRDA.
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Accumulation of Drosophila p62 in
Frataxin-Deficient Glial Cells
Marf has been extensively described as a mediator of
mitochondrial fusion in mammals as well as in Drosophila
(Westermann, 2010; Corti et al., 2011) and it has been reported
to be a substrate of the ubiquitin ligase Parkin in the mitophagy
process (Pallanck, 2013;Wang et al., 2016). Therefore, the genetic
interaction withMarf downregulation might indicate alterations
in mitochondrial morphology and degradation upon frataxin
silencing in glial cells.
In order to address this question, we decided to focus on
one type of glial cell, the giant glial cells (GGCs) of the inner
and outer optic chiasms on both sides of the medulla (Tix et al.,
1997). These glial cells are a specialized form of ensheathing
glia that wraps axonal tracts which project between neuropils.
They are suitable for our analysis because of their large size and
their location in the region that shows strong brain vacuolization
upon frataxin silencing (Navarro et al., 2010). Mitochondria
were visualized in glia by means of a mitochondria-targeted
GFP (mitoGFP). The analysis of mitoGFP pattern between
controls (Figures 2A,B; UAS-mitoGFP/+; Repo-GAL4/UAS-
mcherryRNAi) and frataxin-deficient flies (Figures 2C,D;
UAS-mitoGFP/+; Repo-GAL4/fhRNAi-1) did not reveal any
remarkable difference in the distribution or morphology of
mitoGFP signals throughout the glia. It is well known that
reduction of frataxin expression affects mitochondrial function.
However, the small cell size of glia and the structure of
the Drosophila brain impedes the analysis of mitochondrial
activity in our experimental scenario. Importantly, damaged
mitochondria are normally degraded by a special form of
autophagy called mitophagy (Westermann, 2010). Similarly to
mammalian p62, the Drosophila ortholog Ref(2)P (hereafter
referred to as p62) is also a classical marker of autophagic flux in
the fly (Nezis et al., 2008; Pircs et al., 2012; Mauvezin et al., 2014).
Interestingly, it has been recently reported that fly p62 might
also be useful to monitor mitochondrial clearance by mitophagy
upon organelle dysfunction (Wang et al., 2016). Reduction of
frataxin expression in glial cells induced accumulation of p62 in
our region of interest (denoted area, Figure 2F) compared
to controls (Figure 2E). However, the difference could not
be observed by western blot (Figure 2G), likely because of a
general overall accumulation of p62 in aged brains (Nezis et al.,
2008). Despite the accumulation of p62, targeted silencing of
frataxin did not induce loss of GGCs (Figure 2H). Our results
might suggest that frataxin deficiency in glial cells either blocks
autophagy or increases the number of mitochondria labeled for
degradation.
Frataxin Depletion in Drosophila Muscle
Cells Alters Mitochondrial Dynamics
In order to address this question, we expanded our analysis to
indirect flight musculature (hereafter referred to as muscles).
Drosophila muscles comprise a large number of mitochondria
and therefore, this tissue is extremely sensitive to mitochondrial
perturbations which can be easily visualized and studied
by histological approaches (Greene et al., 2003; Clark et al.,
2006; Deng et al., 2008). By means of two different RNAi
lines, our results demonstrate that frataxin knockdown in
muscles reproduces the main features of the disease including
reduced longevity and locomotion and impaired aconitase
activity, ATP production and mitochondrial membrane
potential (Supplementary Figure S1) in agreement with
Lodi et al. (1999) and Vorgerd et al. (2000). Compared to
controls (Supplementary Figures S2A, 3A), we also found
that mitochondria in frataxin-deficient muscles display an
age-dependent mitochondrial fragmentation from day 1 on
(normal morphology, Supplementary Figure S2B) to day
10 (fragmented, Figure 3B). In line with the fragmentation,
analysis of the expression profile of genes involved in
mitochondrial dynamics and quality control showed important
alterations (Supplementary Figure S2E). Interestingly, an
increased mitochondrial fragmentation, as we have observed
in frataxin-deficient muscles, is consistent with mitochondria
being targeted for clearance by mitophagy (Palikaras and
Tavernarakis, 2014). Indeed, frataxin-deficient muscles
displayed a clear increase of p62 positive signals (Mef2-
GAL4/fhRNAi-1; Figure 3D) compared to controls (Mef2-
GAL4/UAS-mcherryRNAi; Figure 3C). Western blot analysis
also showed that p62-levels were 4–8 times higher in frataxin-
deficient flies than in controls and that they increased by
2-fold between 1-day-old and 10-day-old flies (Figure 3E). This
was further confirmed by the analysis of number and size of
p62-positive signals at three different ages (Supplementary
Figures S2H–J). Interestingly, our results also show that
mitochondrial dysfunction preceeds the organelle fragmentation
since p62 starts to accumulate and mitochondrial TMRE
signal is already decreased in 1-day-old flies (Figure 3E
and Supplementary Figure S1L, respectively). Remarkably,
p62 formed vesicle-like structures that are engulfing damaged
mitochondria for degradation (Figure 3D and Supplementary
Figure S2L). In most of the cases, similar results were observed
with a second independent RNAi line for frataxin (fhRNAi-
2, Supplementary Figure S2). Furthermore, mitochondrial
DNA (mtDNA) content positively paralleled p62 levels
(Supplementary Figure S2M) suggesting a clear mitochondrial
accumulation. Our results show that frataxin deficiency in
muscles alters mitochondrial dynamics and confirms that
frataxin downregulation in the fly triggers accumulation of p62.
Interestingly, the formation of p62-positive vesicles suggests a
specific effect on mitophagy rather than a general autophagy
dysfunction.
Mitophagy Is Not Impaired in
Frataxin-Deficient Cells
On the one hand, the detection of p62-positive vesicles
indicates that the mitochondrial quality control mechanism
driven by pink1 and parkin is working properly in frataxin-
deficient flies. On the other hand, accumulation of p62 inversely
correlates with autophagic degradation (Bartlett et al., 2011;
Pircs et al., 2012) and might indicate a failure of the
autophagosome-lysosomal pathway. Therefore, we decided to
study the autophagic flux in frataxin-deficient cells analyzing
the amount and cellular distribution of two autophagy markers,
LAMP1GFP and GFPATG8a, in both tissues (Figure 4). Our
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FIGURE 4 | Enhanced mitophagic flux in frataxin-deficient cells. (A) Western blots showing levels of LAMP1GFP and GFPATG8a markers as well as Free GFP levels
in controls and FRDA brain samples. (B,C) Quantification of blot in (A). Strong reduction of protein levels of LAMP1GFP and GFPATG8a markers and increased
levels of Free GFP upon frataxin silencing in glia cells. These results suggest increased mitophagic flux in glia. (D) Representative picture of LAMP1GFP and
p62 patterns in 5-day-old frataxin-deficient flies (UAS-LAMP1GFP/+; Mef2-GAL4/fhRNAi-1). Increased punctuate structures. Arrows denote colocalization of both
signals. (E) Representative picture of GFPATG8a and p62 patterns in 5-day-old frataxin-deficient flies (fhRNAi-1/+; Mef2-GAL4/UAS-GFPATG8a). Arrows denote
colocalization of both signals. (F) Quantification of colocalization between p62 and GFPATG8a and LAMP1GFP signals referred to the total amount of p62 vesicles.
Correct recruitment of autophagic machinery. (G) Representative picture of mtRosella and p62 patterns in 5-day-old control flies (Mef2-GAL4/UAS-mtRosella).
Presence of both mtRosella signals in all mitochondria and absence of p62 signals. (H) Representative picture of mtRosella and p62 patterns in 5-day-old
frataxin-deficient flies (fhRNAi-1/+; Mef2-GAL4/UAS-mtRosella). Presence of both signals in all mitochondria that have not been targeted for clearance
(p62 negative). Arrows denote engulfed mitochondria that have lost dsRed and pHluorin signals. Asterisks denote mitochondria that only retained dsRed signal
indicating location in the lysosomal compartment. A small population of p62-positive mitochondria still showed both mtRosella signals (arrow head). (I) Evaluation of
colocalization between p62 and mtRosella signals referred to the total amount of p62 vesicles. Reduced percentage of mitochondria displaying all three signals
(p62 and dsRed/pHluorin from mtRosella) whereas the majority showed only the pH-resistant dsRed or complete loss of any mtRosella signal, indicating correct
clearance of defective mitochondria. Scale bars represent 10 µm in all cases. All graphs represent means ± SEM. Statistical analysis in (B,C) was performed by
Unpaired T-test. ∗∗∗P < 0.001.
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FIGURE 5 | Marf silencing neither modifies the mitochondrial network nor improves mitochondrial degradation in FRDA glia. (A,B) Representative pictures of
mitoGFP-labeled mitochondria from GGCs in 35-day-old frataxin-deficient (A, fhRNAi-1/UAS-mitoGFP; Repo-GAL4/UAS-mcherryRNAi) and frataxin-deficient
coexpressing Marf silencing (B, fhRNAi-1/UAS-mitoGFP; Repo-GAL4/UAS-MarfRNAi) flies. Mitofusin downregulation did not alter the mitochondrial morphology in
frataxin-deficient glial cells. (C,D) Examples of p62 staining of 35-day-old frataxin-deficient GGCs coexpressing UAS-MarfRNAi (fhRNAi-1/+;
Repo-GAL4/UAS-MarfRNAi). The presence of p62-positive structures suggests that improvement of FRDA phenotypes is not a consequence of enhancing
mitochondrial function or stimulation of mitophagy. (E–L) Representative images of brains from 35-day-old flies displaying frataxin knockdown in glial cells (fhRNAi-1;
Repo-GAL4) along with coexpression of UAS-Opa1RNAi (E), UAS-Opa1 (F), UAS-Drp1RNAi (G), UAS-Drp1 (H), UAS-Pink1RNAi (I), UAS-Pink1 (J),
UAS-ParkinRNAi (K) and UAS-Parkin (L). (M) Quantification of degenerated area (%) in 35-day-old frataxin-deficient flies. Genetic manipulation of mitochondrial
fusion and fission or mitochondrial quality controls did not rescue brain vacuolization. (N) p62 staining of 35-day-old frataxin-deficient GGCs coexpressing
UAS-Parkin (fhRNAi-1/ UAS-Parkin; Repo-GAL4/+). Induction of mitophagy by parkin overexpression did not improve accumulation of p62. Scale bars represent
40 µm in (A–D,N) and 50 µm in the other panels. Graph in (M) represents means ± SEM. Statistical analysis was performed by One-way ANOVA with post hoc
Dunnett Multiple Comparison test. ∗∗∗P < 0.001.
Western Blot analysis in glial cells (Figures 4A,B) showed that
the levels of both proteins were decreased by around 80% in
frataxin-deficient brains. Accordingly, levels of free GFP were
increased (Figure 4C). Appearance of cleaved GFP has been
previously linked to an efficient flux (Mauvezin et al., 2014;
Bargiela et al., 2015). These results suggested an increased
mitophagic flux. The small size of lysosomes, autophagosomes
and mitochondria in glia (Supplementary Figures S3A–D and
Figure 5A) prevented a reliable and robust histological analysis
to confirm our findings.We then decided to address this question
in the fly muscles. Compared to controls (Supplementary
Figures S3F,G), we found a strong accumulation of punctate
signals of both autophagy markers in frataxin-deficient muscles
(arrows in Figures 4D,E) along with a partial colocalization of
p62 with LAMP1GFP or GFPATG8a (Figure 4F, 20% and 70%,
respectively). This result indicated a correct recruitment of the
autophagic machinery to form autophagosomes (GFPATG8a),
although formation of the autophagolysosomes might be a
limiting step (LAMP1GFP). Similarly to glial cells, molecular
analysis in muscles also suggested enhanced cleavage and
turnover of LAMP1GFP, albeit to a lesser extent (Supplementary
Figure S3E). In order to study whether the problem may lie in
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FIGURE 6 | Frataxin depletion alters endoplasmic reticulum (ER) stress response in glia. (A) Representative image of 35-day-old control GGCs (UAS-Xbp1GFP/+;
Repo-GAL4/+) stained with anti-Repo antibody to label cell nuclei. Strong and panglial induction of spliced Xbp1 that localizes in the cell nuclei. (B) Representative
image of 35-day-old frataxin-deficient GGCs (fhRNAi-1/UAS-Xbp1GFP; Repo-GAL4/+). Induction of spliced Xbp1 was completely abolished. (C) Representative
image of 35-day-old control GGCs (Repo-GAL4/UAS-mcherryRNAi) stained with anti-BiP to monitor ER stress levels. No induction of BiP. Arrows denote the area of
interest. (D) Representative image of 35-day-old frataxin-deficient GGCs (Repo-GAL4/fhRNAi-1) stained with anti-BiP. Strong activation of ER stress response via
induction of BiP levels. (E,F) Lack of Xbp1GFP induction already detected in young (7-day-old) frataxin deficient flies (F) compared to age-matched control (E).
(G,H) Coexpression of human frataxin (FXN) restores the nuclear localization of Xbp1GFP (G) and BiP expression (H) to wild type levels. Scale bars represent 40 µm
in all cases.
the inability to complete the degradation of the mitochondria, we
have generated transgenic flies to express themtRosella transgene
and perform analysis of mitophagy in vivo. This construct
consists of a mitochondria-targeted dsRed fluorescent protein
fused to a pH-sensitive GFP named pHluorin. Under normal
conditions, the green and red signals overlap in mitochondria,
whereas, upon mitophagy, degenerating mitochondria are
transferred to lysosomal compartments and the green signal
is lost due to the low pH (Rosado et al., 2008). We have
observed that, in controls, all mitochondria clearly showed both
signals (Figure 4G). In frataxin-deficient flies, dysfunctional
mitochondria were first marked with p62, which still showed
both mtRosella signals (arrow heads in Figure 4H). Then,
damaged organelles were incorporated into the autophagosome
and, after fusion with lysosomes, the acidic pH eliminated the
green sensitive signal from the pHluorin (asterisks in Figure 4H).
Finally, the process of mitochondrial clearance was completed
and the red signal from mtRosella marker was also depleted
(arrows in Figure 4H). As expected, all mitochondria that
were not enveloped by p62-vesicles displayed both signals.
Quantification of the population of mitochondria that have
entered the mitophagy process (p62-positive mitochondria)
showed three groups of organelles: a reduced fraction (7%)
displayed both signals (Figure 4I, yellow bar), a substantial 23%
only displayed dsRed indicating incorporation into lysosomal
compartment (Figure 4I, red bar) and importantly, the majority
(70%) of the labeled mitochondria seemed to have lost both
mtRosella signals (Figure 4I, white bar).
Altogether, our results clearly exclude mitophagy dysfunction
in frataxin-deficient flies and thus, accumulation of p62 may
suggest that the normal cellular capacity is insufficient to
deal with the increasing number of damaged mitochondria.
Therefore, we tested whether promotion of autophagy might
improve FRDA conditions. Expression of the autophagy marker
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FIGURE 7 | Muscle-specific and ubiquitous reduction of frataxin function triggers ER stress. (A) Representative image of 7-day-old control muscles
(UAS-Xbp1GFP/+; Mef2-GAL4/+) stained with DAPI to label cell nuclei and phalloidin to label F-actin in muscle fibers. No induction of spliced Xbp1 was observed.
(B) Representative image of 7-day-old frataxin-depleted muscles (UAS-Xbp1GFP/fhRNAi-1; Mef2-GAL4/+) stained with DAPI to label cell nuclei and phalloidin to
label to label F-actin in muscle fibers. Strong induction of spliced Xbp1 was detected in cell nuclei. (C) Relative expression levels of BiP/GRP78 in muscles of
7-day-old controls (Mef2-GAL4/UAS-mcherryRNAi) and frataxin-deficient muscles (Mef2-GAL4/fhRNAi-1). Robust (2-fold) activation of BiP/GRP78 in FRDA flies.
(D) Increased phosphorylation levels of eI2Fα in frataxin-deficient muscles. All these results indicate activation of all three branches from the unfolded protein
response (UPR) and the boost of ER stress response in FRDA muscles. (E,F) Quantification of phosphorylation levels of eI2Fα in two additional models of FRDA.
(E) A mutant allele of frataxin (fh1) and (F) a second RNAi line (fhRNAi-2). Significantly increased phosphorylation is detected in both cases, although only in old flies,
when fhRNAi-2 was used. Scale bars represent 10 µm in all cases. Data in (C–F) were analyzed by Unpaired T-test. Means ± SEM. ∗P < 0.05; ∗∗P < 0.01;
∗∗∗P < 0.001.
GFPATG8a in glial cells was accompanied by a clear reduction
of p62 levels (Supplementary Figure S4A) and of brain
vacuolization (Supplementary Figures S4B,D) compared to the
expression of LAMP1GFP (Supplementary Figures S3B, S4C,D,
respectively). Since it might be controversial whether GFPATG8a
is a functional protein, we repeated the experiment using an
independent UAS-ATG8a line and reduction of p62 levels
and brain vacuolization were also observed (Supplementary
Figures S4D–F). The effect of genetic autophagy induction
was also detected in muscles. Our experiments revealed that
overexpression of GFPATG8a triggered a strong reduction of
p62 levels (40%) in FRDA muscles compared to the expression
of two other GFP markers such as LAMP1GFP and ERGFP
(Supplementary Figure S4G). However, chemical induction
of early autophagy by means of rapamycin failed to improve
locomotion and brain degeneration upon depletion of frataxin
in glia (Supplementary Figures S4H,I).
Marf Silencing Fails to Improve
Mitochondrial Homeostasis in Glial Cells
Since promotion of autophagy had a positive impact on FRDA
phenotypes, we decided to analyze whether the rescue of frataxin-
deficiency, which is triggered by Marf downregulation, was
due to the enhancement of mitochondrial clearance or to any
additional modification of the mitochondrial network. Marf
knockdown in frataxin-deficient glial cells (Figure 5B) did not
produce any visible effect on mitochondrial morphology and
distribution compared to frataxin-deficient glia (Figure 5A).
In agreement, neither reduction of Opa1 (Marf partner in
mitochondrial fusion) nor overexpression of Drp1 (fission
mediator) were able to ameliorate the locomotor dysfunction
(Figure 1A) and the brain vacuolization triggered by glial frataxin
deficiency (Figures 5E–H and quantification in Figure 5M).
These results suggest that fusion and fission of mitochondria
are not the driving force underlying mitofusin-mediated
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FIGURE 8 | Marf regulates ER stress in frataxin deficient glial cells. (A) Representative image of 35-day-old frataxin-deficient GGCs coexpressing a control construct
(fhRNAi-1/+; Repo-GAL4/ UAS-mcherryRNAi) stained with anti-BiP. A second UAS line does not influence BiP induction in frataxin-deficient flies. (B) Representative
image of 35-day-old frataxin-deficient GGCs coexpressing a MarfRNAi construct (fhRNAi-1/+; Repo-GAL4/ UAS-MarfRNAi) stained with anti-BiP. Clear suppression
of BiP induction by Marf silencing. (C) Representative image of 35-day-old control GGCs (Repo-GAL4/ UAS-MarfRNAi) stained with anti-BiP. In contrast to muscles
(Debattisti et al., 2014), Marf downregulation in glia did not induce BiP expression. (D) Representative image of 35-day-old frataxin-deficient GGCs coexpressing
Marf downregulation and the Xbp1GFP reporter (fhRNAi-1/UAS-Xbp1GFP; Repo-GAL4/ UAS-MarfRNAi) stained with anti-BiP. Nuclear localization of Xbp1 and BiP
expression were restored to wild type levels. (E) A second RNAi line to downregulate Marf expression also reduces BiP immunoreactivity in FRDA flies (fhRNAi-1/+;
Repo-GAL4/UAS-MarfRNAi(TRiP)). In all cases, scale bars represent 40 µm.
rescue. Next, we tested whether Marf silencing was able to
improve autophagic flux and to reduce p62 accumulation.
Marf knockdown in frataxin-deficient glial cells failed to
reduce p62 levels (Figures 5C,D). In this line of findings,
suppression or overexpression of the mitochondrial quality
control genes Pink1 and Parkin (master regulators of mitophagy)
failed to ameliorate any frataxin-deficient phenotypes such as
negative geotaxis (Figure 1A), brain degeneration (Figures 5I–L
and quantification in Figure 5M) and p62 accumulation
(Figure 5N).
Remarkably, these results suggest thatMarf silencing rescued
FRDA phenotypes without improving mitochondrial function
and that the protection mediated by Marf inhibition is mainly
independent ofMarf roles in mitochondrial fusion and clearance
by mitophagy.
Altered Endoplasmic Reticulum Stress
Reponse in FRDA Flies
In mammalian cells, mitofusins are also involved in the interface
between mitochondria and endoplasmic reticulum (ER). These
connections facilitate the exchange of lipids and calcium
and promote mitochondrial fission (van Vliet et al., 2014).
Interestingly, Marf downregulation has been shown to induce
ER stress in Drosophila muscles (Debattisti et al., 2014). ER
stress activates in turn the unfolded protein response (UPR).
Such a response is mediated by pancreatic ER kinase (PERK),
inositol-requiring enzyme 1 (IRE1) and activating transcription
factor 6 (ATF6), which trigger three cascades characterized by
the increased expression of downstream transcription factors
named ATF4, Xbp1 and the chaperone BiP/GRP78 (reviewed in
Hetz and Mollereau, 2014). Importantly, the UPR is conserved
in Drosophila and has already been associated with some fly
models of neurological disorders (reviewed in Ryoo, 2015). This
motivated us to determine whether frataxin silencing in flies was
also affecting the ER morphology and stress.
First, we tested in vivo in 35-day-old brains whether frataxin-
deficiency in glia cells induced some markers of ER stress
such as increased levels of the protein BiP and of a Xbp1GFP
reporter, which is only expressed in-frame with GFP when
IRE1-mediated splicing of Xbp1 occurs (Sone et al., 2013).
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FIGURE 9 | Chemical reduction of ER stress improves FRDA conditions. (A–C) Representative images of 35-day-old frataxin-deficient (Repo-GAL4/fhRNAi-1) GGCs
stained with anti-BiP to monitor ER stress levels. Clear reductiion of BiP induction by tauroursodeoxycholic acid (TUDCA) (B) and 4-phenylbutyric acid (4-PBA) (C)
treatments compared to untreated flies (A). (D–F) Representative images of paraffin brain sections from 35-day-old flies displaying frataxin knockdown in glial cells
(fhRNAi-1; Repo-GAL4) untreated (D) or treated with 15 mM TUDCA (E) and 7.5 mM PBA (F). (G) Quantification of degenerated area (%) in 35-day-old
frataxin-deficient flies. Treatment with chemical chaperones such as TUDCA and PBA partially rescued brain vacuolization in FRDA flies. (H) Negative locomotor
performance of 5-day-old controls and FRDA flies treated with TUDCA and PBA. No recovery of locomotor deficit in frataxin-deficient flies. (I,J) Representative
images of retinas of 5-day-old fh1 mutant clones either untreated (I) or treated with TUDCA (J). TUDCA administration seems to prevent photoreceptor neuron
degeneration. (K) TUDCA and PBA supplementation protect aconitase activity. Frataxin-deficient flies showed a strong reduction of the enzymatic activity under
oxidative insult. Administration of TUDCA and PBA increased aconitase activity by 25%. Scale bars represent 40 µm in (A–C), 50 µm in (D–F) and in 10 µm (I,J). In
all graphs data is shown as means ± SEM. Data was analyzed by One-way ANOVA with post hoc Tukey Multiple Comparison Test. ∗∗P < 0.01; ∗∗∗P < 0.001.
Surprisingly, we detected that spliced Xbp1 was constitutively
expressed in nuclei of control cells (Figure 6A), whereas its
expression was completely abolished upon frataxin deficiency
(Figure 6B). The lack of Xbp1 induction in FRDA glial cells
was already evident in young flies (Figure 6F) compared to age-
matched controls (Figure 6E). Interestingly, we found that FRDA
flies exhibited increased BiP immunoreactivity (Figure 6D)
compared to controls (Figure 6C) in the region of interest
(arrows in Figure 6C). Activation of ER stress pathways in the
glia was not accompanied with evident morphological defects
in the ER (Supplementary Figures S5A,B). In order to exclude
the influence of off-targets in the ER stress response observed
upon targeted silencing of frataxin in glia, altered levels of
Xbp1 reporter as well as chaperone BiP were analyzed after
coexpression of human frataxin (UAS-FXN). Human frataxin
is insensitive to RNAi contructs against fly frataxin and has
already improved frataxin-deficient conditions in other tissues
(Navarro et al., 2011; Tricoire et al., 2014). As expected,
expression of FXN restored Xbp1 expression (Figure 6G) and
reduced BiP levels (Figure 6H) in frataxin-deficient glia. The
altered ER stress response was not restricted to glial cells.
Frataxin knockdown in muscles also triggered the activation of
all three UPR branches (Figures 7A–D). In this case, frataxin-
deficient muscles displayed a strong nuclear signal of the
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Xbp1 reporter, whereas controls did not show any activation
(Figures 7A,B). Frataxin-deficient muscles also showed elevated
levels of BiP (Figure 7C) and of phosphorylated α subunit of
eukaryotic translation initiation factor 2 (eIF2α; Figure 7D), a
known marker of ER stress via PERK signaling (Celardo et al.,
2016). An increased clustering of ER cisternae (Supplementary
Figures S5C,D) was also detected in FRDA muscles. Moreover,
we also took advantage of a severe loss-of-function allele of
fly frataxin (fh1, Chen et al., 2016b) and of a second RNAi
line that decreases frataxin expression to levels similar to those
observed in patients (fhRNAi-2, Llorens et al., 2007). In both
cases (Figures 7E,F), severe and moderate ubiquitous loss of
frataxin also increased the levels of phosphorylated eIF2α.
However, since phospho-eIF2α levels can be also increased by
other pathways (Baker et al., 2012), we cannot completely rule
out that other mitochondrial stress responses are also influencing
the increase detected in fh1 and fhRNAi-2 flies. These results
clearly suggest that frataxin-depletion dramatically alters the
ER stress response ubiquitously and specifically in glia and
muscles.
Endoplasmic Reticulum Stress Is an
Instrumental Pathological Element in FRDA
Next, we addressed whether Marf was modulating the ER
stress response in frataxin-deficient glia. Remarkably, Marf
downregulation using two independent RNAi lines was sufficient
to strongly reduce BiP expression in 80% of the frataxin-
deficient flies analyzed (Figures 8B,D,E) compared to frataxin-
deficient flies coexpressing mcherryRNAi (Figure 8A) and to
restore expression of spliced Xbp1 in frataxin-deficient GGCs
(Figure 8D). It is important to note that Marf downregulation
in glia did not seem to trigger any ER stress response by itself
(Figure 8C), whereas it does in Drosophila muscles (Debattisti
et al., 2014). Our results suggest that mitofusin mediates the
ER stress response in frataxin-deficient glia and therefore Marf
downregulation is able to compensate the altered ER stress
response and concomitantly reverses the locomotor dysfunction,
the brain degeneration and the accumulation of lipid droplets
(Figures 1A,C,I), the main hallmarks of frataxin downregulation
in the Drosophila glia (Navarro et al., 2010).
Finally, to further analyze the impact of ER stress in
our FRDA model, we decided to test whether two chemical
chaperones, TUDCA and 4-PBA, which have been shown to
attenuate ER stress (Debattisti et al., 2014; Celardo et al.,
2016), were sufficient to improve frataxin-deficient phenotypes.
Uptake of 15 mM TUDCA or 7.5 mM PBA was able
to clearly reduce the BiP immunoreactivity of FRDA flies
(Figures 9A–C) in the region of interest (arrows in Figure 9A)
and concomitantly, both were able to promote a strong reduction
of around 45% of the brain vacuolization triggered by frataxin
depletion in glia (Figures 9D–G) which is similar to Marf
downregulation (65%, Figure 1F). However, TUDCA and PBA
did not improve the locomotion defects induced by glial-
targeted frataxin silencing (Figure 9H) suggesting that other
factors besides ER stress might be involved in this defect.
Following the strategy described by Chen et al. (2016b), we
generated mosaic mutant clones of Drosophila photoreceptor
neurons by means of the Flippase/Flippase Recognition Target
(FLP/FRT)-system and we analyzed the morphology of the
photoreceptors in 5-day-old flies upon treatment with TUDCA.
Compared to untreated flies (Figure 9I), application of
the drug during development and adulthood helped to
maintain the structural integrity of the photoreceptors and
reduced the degeneration (Figure 9J). We and others have
already shown that frataxin silencing with fhRNAi-2 decreases
aconitase activity under oxidative stress (Llorens et al., 2007;
Navarro et al., 2010, 2015). Moreover, this model has been
reported as an interesting tool to test drugs that might
improve FRDA conditions (Soriano et al., 2013; Calap-Quintana
et al., 2015). As shown in Figure 9K, TUDCA and PBA
were able to moderately increase aconitase activity (25%) in
frataxin deficient flies (fhRNAi-2/+; actin-GAL4/+) without
affecting the aconitase activity of controls (actin-GAL4/UAS-
mcherryRNAi).
These experiments clearly indicate a positive effect by
reducing the ER stress in frataxin-deficient flies and links ER
stress with the neurodegeneration observed in the FRDA nervous
system. Our results highlight ER stress as a crucial mediator
in FRDA as well as a new cellular process for therapeutic
interventions.
DISCUSSION
FRDA is the most common recessive ataxia in the Caucasian
population. Reduction of frataxin expression affects the
synthesis of iron-sulfur clusters as well as the cellular metabolism
of iron and the mitochondrial production of ATP leading
to mitochondrial dysfunction and concomitant cellular
degeneration and death. In the last decade, Drosophila has
become one of the most powerful and attractive models to study
targeted frataxin deficiency in several tissues such as peripheral
and central nervous system, glia and heart (Anderson et al., 2008;
Navarro et al., 2010; Shidara and Hollenbeck, 2010; Tricoire
et al., 2014; Chen et al., 2016b) as well as in the whole organism
(Anderson et al., 2005; Llorens et al., 2007; Calap-Quintana et al.,
2015).
FRDA is a mitochondrial pathology and indeed, alterations
in mitochondrial morphology ranging from enlarged organelles
(Bolinches-Amorós et al., 2014; Obis et al., 2014) to increased
fragmentation (Lefevre et al., 2012; Schiavi et al., 2015)
have been reported in FRDA models. However, very few
reports have carried out a systematic and comprehensive
analysis of the mitochondrial dynamics in cells lacking
frataxin. We have addressed this question using our model
for frataxin-defiency in glial cells (Navarro et al., 2010,
2015). We initially performed a forward genetic screen
to decipher more genetic interactions linking mitochondrial
dynamics and frataxin knockdown. Our results revealed the
Drosophila Mitofusin homolog (Marf ) as a key mediator of
the pathology in the glia. Marf downregulation was able
to fully recuperate some of the most important phenotypes
induced by frataxin silencing in glia such as the locomotor
dysfunction, the brain degeneration and the accumulation of
lipid droplets in the brain (Navarro et al., 2010). In agreement
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FIGURE 10 | Proposed model for Marf-mediated ER stress in FRDA flies. (A) Model suggested by our results. In short, mitofusin regulates the ER stress response in
frataxin-deficient glia likely by mitochondria-ER tethering. Marf silencing is able to normalize the altered ER stress response and concomitantly to reverse the
locomotor dysfunction, the brain degeneration and the accumulation of lipid droplets. (B) Hypothetical graphical model showing that ER-mitochondrial contacts
might be mediating different phenotypes described in FRDA models. On the one hand, frataxin deficiency increases mitochondrial iron concentration. In parallel, iron
stimulates sphingolipid synthesis in the ER. Sphingolipids activate the Pdk1/Mef2 pathway and might induce ER stress leading to cell death. Whether a transport of
iron from the mitochondria to the ER is underpinning this effect still has to be demonstrated (Fe?). On the other hand, frataxin downregulation in mammalian cells has
been shown to abolish mitochondrial buffering capacity for calcium. This results in an increased concentration of cytosolic calcium by inhibiting SERCA pumps,
downregulating the calcium transporter NCLx and opening the MPTP. High calcium activates the nNOS pathway and the transcription factors CREB and NFAT3,
leading also to cell death. Importantly, some crucial sphingolipids are synthesized in the MAMs and MAMs play critical roles in the regulation of Calcium homeostasis.
Ca, Calcium; CREB, cAMP response element-binding protein; ER, Endoplasmic Reticulum; Fe, Iron; MAMs, Mitochondria-associated membranes, Mef2, myocyte
enhancer factor-2; MPTP, Mitochondrial Permeability Transition Pore; nNOS, Neuronal nitric oxide synthases; Pdk1, 3-phosphoinositide dependent protein kinase-1.
with the reduction of lipid accumulation observed in this
work upon Marf knockdown, Marf mutants also display
reduced number of lipids (Sandoval et al., 2014). Importantly,
Marf silencing did not affect frataxin levels (Supplementary
Figure S6A).
The strong genetic interaction with Marf initially suggested
critical alterations of mitochondrial dynamics in frataxin-
deficient cells. Studies in Drosophila muscles have provided
remarkable evidence regarding mitochondrial homeostasis
(Clark et al., 2006; Deng et al., 2008; Wang et al., 2016).
Because of this, we decided to establish Drosophila IFM as a
platform to study frataxin deficiency. Frataxin downregulation
in this mitochondrial-enriched tissue recapitulates the basic
physiological and biochemical defects observed in patients
(Beauchamp et al., 1995; Lynch et al., 2002; Nachbauer et al.,
2012). Frataxin deficiency in Drosophila muscles induced
mitochondrial fragmentation that was accompanied by changes
in the expression levels of genes involved in mitochondrial
fusion and fission (Opa1, Marf and Drp1) and in mitochondrial
quality control (Pink1). However, a similar analysis performed
in yeast did not report any difference (Lefevre et al., 2012).
Interestingly, three of these modifications (upregulation of
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Opa1 and downregulation of Drp1 and Pink1) are consistent
with the promotion of mitochondrial fusion. However, since
fragmentation is critical to avoid ‘‘contamination’’ of healthy
mitochondria through fusion with damaged or senescent
mitochondria (Bhandari et al., 2014), the observed expression
profile might represent a pathological downstream consequence
of frataxin deficiency.
Mitochondrial fragmentation and perinuclear clustering
normally precedes clearance by means of a special form of
autophagy called mitophagy (Okatsu et al., 2010; Palikaras and
Tavernarakis, 2014). We have detected in glia and muscles of
FRDA flies that damaged mitochondria are correctly labeled
and targeted for degradation, indicating an effective integration
of mitochondrial checkpoints. However, we also detected
accumulation of the autophagy marker p62. A similar result
has also been found in the cardiac tissue and sensory neurons
of an FRDA mouse model (Huang et al., 2013; Mollá et al.,
2017, respectively). Moreover, lysosomes and autophagosomes
seem to accumulate in the DRG of FRDA rodent models (Simon
et al., 2004; Al-Mahdawi et al., 2006). Several reports have linked
such accumulations to a deficient autophagy process (reviewed
in Mauvezin et al., 2014). Thus, it is necessary to elucidate
whether frataxin silencing induces or blocks autophagy. This
question has recently been addressed in C. elegans (Schiavi
et al., 2015). Using histological markers, the authors concluded
that the autophagic flux remained intact. However, the worm
possesses the peculiarity of being the only FRDA model that
displays an extended longevity upon strong frataxin depletion.
Therefore, we decided to perform a detailed investigation
of the autophagy-mitophagy process in two different tissues,
muscle and glia, in a Drosophila FRDA model that shows
the expected shortened lifespan (this work and Navarro et al.,
2010).
In our approach, we have shown that autophagosomes are
properly recruited and autophagolysosomes are also generated.
In addition, our molecular analysis of the turnover rate of
the autophagy markers suggested an enhanced flux which
was much more evident in glia than in muscles. The careful
analysis of the mtRosella marker clearly showed that the
majority of damaged organelles have lost both, the pH-sensitive
and the pH-insensitive markers, as a strong indication of
functional mitophagy. The mtRosella transgene has already
been demonstrated to be a powerful tool to analyze mitophagy
in vivo in yeast (Rosado et al., 2008; Böckler and Westermann,
2014), worms (Schiavi et al., 2015) and mammalian systems
(Sargsyan et al., 2015). Our generation of the first fly
stock that expresses this construct incorporates Drosophila
to this group of model organisms and further expands the
Drosophila tools to study autophagy and mitophagy. One of
the main problems in the field of frataxin research is the
lack of homogeneous results between different models. The
information given by a specific readout or marker might
reflect the singularity of each model or each experimental
scenario. This work highlights that induction of mitophagy is a
physiological hallmark in each single FRDA model and it might
represent a new pathway to unveil potential biomarkers of the
disease.
Interestingly, our analysis has also revealed that expression of
a GFPATG8a marker was sufficient to reduce p62 accumulation
as well as to improve brain degeneration. This result might
suggest that on the one hand, GFPATG8a is not a neutral
marker and it is potentially generating a gain-of-function
situation that stimulates autophagy and that on the other hand,
induction of autophagy might also be a beneficial therapeutic
approach in FRDA. Although there is still controversy about the
functionality of ATG8a markers, their ability to work as wild
type proteins has also been shown for other ATG8a constructs
(Pircs et al., 2012). Our result was further supported by the
effects observed upon overexpression of endogenous ATG8a by
means of an independent UAS-ATG8a line. Unfortunately, the
hypothesis could not be tested by overexpression of another key
autophagy gene such as ATG1 since its expression resulted in
lethality when expressed in glia. On the contrary, expression
of LAMP1GFP did not exert any protective function, likely
because it consists of the fusion between specific domains
of human LAMP1 and eGFP (Jacomin et al., 2016) and this
might explain the lack of an effect. The positive influence of
autophagy suggests that specific enhancing of mitophagy might
have similar effects. Parkin overexpression seemed an attractive
possibility since Parkin promotes mitophagy in mammalian
cells (Geisler et al., 2010). In addition, Marf is ubiquitinated
by Parkin (Ziviani et al., 2010) and thus, increasing Parkin
expression would also reduce the amount of Marf. However
and in contrast to ATG8a, overexpression of Parkin failed
to modify the brain degeneration or p62 accumulation in
our experimental scenario. This is not completely surprsing
since several susbstrates have been predicted to be targets of
Parkin in Drosophila (Martinez et al., 2017) and thus, Parkin
overexpression and Marf silencing represent two complete
different situations. On the other hand, Marf silencing seems
to improve Parkinson’s disease phenotypes independently of
the autophagy process (Liu and Lu, 2010; Celardo et al., 2016).
Marf knockdown has been shown to completely suppress
Pink1 and Parkin loss of function in Drosophila models
of Parkinson’s disease in muscles (Deng et al., 2008; Liu
and Lu, 2010) and in the heart (Bhandari et al., 2014) by
preventing mitochondrial fusion. Interestingly, another report
has recently demonstrated that in the nervous system of
two fly models of Parkinson’s disease, Marf knockdown
rescued phenotypes influencing ER stress (Celardo et al.,
2016) and not mitochondrial dynamics. Remarkably, human
and fly mitofusins have been already described to modulate
cellular responses to ER stress (Muñoz et al., 2013; Debattisti
et al., 2014). All these evidences along with the lack of
rescue by Opa1 downregulation, Drp1 overexpression (both
theoretically equivalent to Marf knockdown) and Parkin
overexpression in our FRDA model suggested that Marf
should be influencing another process in frataxin-deficient
flies.
Increased activity and expression of ER stress markers such
as the activating transcription factor 4 (ATF4), the chaperone
binding immunoglobulin protein (BiP) and phosphorylated
eIF2α have been found in cellular (Cortopassi et al., 2006; Lu
and Cortopassi, 2007) and mouse (Huang et al., 2013) FRDA
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models. In other cases, frataxin depletion sensitized cells to
chemically-induced ER stress and triggered accumulation of
the chaperone BiP/Grp78 (Cnop et al., 2012; Bolinches-Amorós
et al., 2014). Interestingly, ER stress markers are induced even
before some Fe-S dependent enzymatic activities started to
decline in FRDA (Lu and Cortopassi, 2007). The activation
of ER stress responses in FRDA is consistent with different
hypotheses, such as aggregation ofmisfolded Fe-S proteins, redox
alterations and abnormal calcium metabolism. The pathogenic
role of ER stress has been already highlighted in otherDrosophila
models of neurodegenerative diseases (Celardo et al., 2016;
Sanchez-Martinez et al., 2016; López Del Amo et al., 2017).
In agreement, we have observed in our models an altered ER
stress response in glia and muscles. We could detect changes
in all three branches of the UPR by means of increased
expression of BiP, abnormal induction of spliced Xbp1 and
enhanced phosphorylation levels of eIF2α. Unexpectedly, we
found strong induction of the spliced form of Xbp1 and its
translocation to the nucleus in glia of control flies, whereas
this response was completely abrogated in FRDA flies. The
current studies addressing the ER stress response in glial cells
are limited. Constitutive activation of the IRE/Xbp1 pathway
has already been described in larval glial cells and it seems
to be related to their role in generating all the components
for the multi-layered membrane sheaths around neurons (Sone
et al., 2013). Interestingly, the GGCs seem to belong to the
subpopulation of ensheathing glia in the adult brain (Kremer
et al., 2017). Therefore, impaired Xbp1 activation might affect
axonal ensheathment and concomitantly certain protective roles
of glial cells leading to the brain degeneration observed in
these flies. Moreover, loss of function of Drosophila MANF,
a protein produced in glial cells, also reduces the expression
of spliced Xbp1 (Lindström et al., 2016). Besides glia, other
tissues such as larval intestine, fat body, certain neurons,
developing photoreceptors, male reproductive system and the
adult intestinal stem cells also show default activation of
XBP1-based reporters (Ryoo, 2015). Such activation seems to be
pivotal for a proper tissue homeostasis.
Notably, our results demonstrate that Marf knockdown
suppresses the ER stress induced by frataxin-deficiency.
Therefore, our results indicate that this might be the most
important mechanism underpinning the rescue driven by Marf
silencing in FRDA glial cells. This hypothesis has been further
corroborated by feeding the flies with a couple of chemical
chaperones, TUDCA and PBA, which counteract ER stress
including lipid-dependent ER stress (Pineau et al., 2009; Liu
et al., 2014). Remarkably, chemical reduction of ER stress
was sufficient to improve brain integrity and photoreceptor
degeneration. We have also found that both compounds were
able to partially suppress aconitase inactivation in FRDA
flies. These results highlight ER stress as a very attractive and
promising therapeutic approach to treat FRDA. It has been
reported that TUDCA and PBA might also act as antioxidant
agents (Liu et al., 2002; Oveson et al., 2011). Moreover,
antioxidants have been suggested as potential beneficial
treatments in FRDA patients and mouse models (Seznec et al.,
2004; Parkinson et al., 2013, respectively). Our experiments
coexpressing three different antioxidant enzymes showed that,
in agreement with Anderson et al. (2008), only hydrogen
peroxide scavengers (mitochondrial catalase, mitocatalase
and mitochondrial thioredoxin reductase, UAS-TrxmitoB)
seemed to display some positive influence on fly locomotion.
However, both failed to improve brain vacuolization and the
presence of lipid droplets (Supplementary Figure S7). These
results, along with those reported by other Drosophila FRDA
models (Tricoire et al., 2014; Chen et al., 2016b), strongly
question antioxidants as effective therapeutic agents in FRDA
and highlight the relevance of protection mediated by Marf
silencing. The lack of effects upon rapamycin treatment is also in
agreement with this idea since it has been suggested to activate
antioxidant pathways in a fly model of FRDA (Calap-Quintana
et al., 2015) in contrast to yeast in which rapamycin reduced
mitochondrial mass likely by stimulating mitophagy (Marobbio
et al., 2012).
We have also found differences in relation to the severity of
the defects and the nonsynchronous progression of the pathology
in different tissues. We speculate that glial mitochondria are
progressively targeted for degradation whereas in muscles the
accumulation of damaged organelles is too substantial in a very
short period of time. The mitochondria labeled for clearance
cannot be countered at the same speed by the mitophagic
machinery and this, and not an impairment of mitophagy,
triggered the accumulation of p62. In addition, the impact of
other genes in the biology of glia and muscles might also explain
the lack of consistency between our genetic screenings. For
example, Marf downregulation affects locomotion in muscles
(Supplementary Figure S6B) but not in glia (Figure 1A) and
induces ER stress in muscles (Debattisti et al., 2014) but not in
glia (this work).
Mitofusins were some of the first proteins shown to be present
at the core of the interface between mitochondria and ER,
namely mitochondria-associated membranes (MAMs; de Brito
and Scorrano, 2008). MAMs are crucial mediators of several
processes such as calcium signaling, apoptosis, autophagy and
lipid biosynthesis (reviewed in Krols et al., 2016b; Paillusson
et al., 2016). In addition, MAMs have already been linked to
other neurodegenerative disorders, such as Alzheimer’s disease
and amyotrophic lateral sclerosis (Schon and Area-Gomez,
2013; Manfredi and Kawamata, 2016). Due to methodological
limitations, subcellular compartments cannot be distinguished
in Drosophila glial cells in electron microscope preparations
and thus, we could not quantify the number of MAMs in
controls and in FRDA glial cells. Importantly, loss of Marf has
already been shown to reduce the contacts betweenmitochondria
and ER in the ring gland (Sandoval et al., 2014) and in
fly neurons (Celardo et al., 2016). Remarkably, reduction of
mitochondria-ER contacts was sufficient to reduce ER stress
and rescue phenotypes in two Drosophila models of Parkinson’s
disease (Celardo et al., 2016). All these facts along with the
improvement of ER stress upon Marf silencing and the positive
effect of chemical chaperones on FRDA phenotypes suggest
that the role of Marf in the mitochondria-ER axis might be
a key mechanistic element in our fly models. Our results are
also important in light of the mechanisms recently described
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in a new fly model of FRDA (Chen et al., 2016b). Chen
and collaborators found that iron mediates activation of the
sphingolipid metabolism that in turn induces neurodegeneration
in fly photoreceptors via the Pdk1/Mef2 pathway. Interestingly,
the same pathway is active in the nervous system of frataxin-
deficient mice as well as in heart samples from FRDA patients
(Chen et al., 2016a). Importantly, sphingolipids are synthesized
in the ER in mammals (Filadi et al., 2017) and flies (Hebbar
et al., 2015) and increased levels have been shown to elicit the
ER stress response in mice (Contreras et al., 2014), cells (Fu
et al., 2011; Liu et al., 2014), flies (Hebbar et al., 2015) and
yeast (Pineau et al., 2009). Furthermore, some sphingolipids
such as ceramide (which is increased in flies and mouse FRDA
models as well as in patients) are specifically synthesized in
MAMs (Stiban et al., 2008; Hayashi and Fujimoto, 2010).
Moreover, we already described a few years ago that frataxin
silencing in glia induced accumulation of lipids (Navarro et al.,
2010) and that enhanced iron import into the mitochondria
was important in the FRDA glial phenotypes (Navarro et al.,
2015). Therefore, it is appealing to speculate that the iron
surplus in FRDA might travel from mitochondria to the ER
through theMAMs to stimulate the iron-dependent sphingolipid
production. However, such a mechanism has not yet been
resolved. Alterations of calcium homeostasis are also known
to induce ER stress (Pineau et al., 2009; Fu et al., 2011;
Contreras et al., 2014; Liu et al., 2014). Regulation of calcium
metabolism is another role that MAMs play in the cell (Krols
et al., 2016a). Interestingly, calcium dyshomeostasis has been
found in different cellular models lacking frataxin (Bolinches-
Amorós et al., 2014; Mincheva-Tasheva et al., 2014; Mollá
et al., 2017; Purroy et al., 2018). In these cases, frataxin
silencing seems to deplete ER calcium stores by inhibiting the
SERCA pump (Bolinches-Amorós et al., 2014). Simultaneously,
the expression of the calcium transporters NCLx and the
mitochondrial permeability transition pore (MPTP) is also
altered (Purroy et al., 2018). All this will increase cytosolic
calcium concentration, that will become toxic in the absence
of the buffering capacity of the mitochondria and will activate
neuronal nitric oxide synthase (nNOS), the cAMP response
element-binding protein (CREB) pathway (Mincheva-Tasheva
et al., 2014) and the NFAT3 factor (Purroy et al., 2018) leading
to cellular hypertrophy and cell death. Unfortunately, this aspect
has never been addressed in the fly FRDA models. All these
evidences from the literature in combination with the results
presented in this work (Figure 10A) might allow developing a
unifying hypothetical model (Figure 10B) in which reduction
of frataxin expression impairs iron-sulfur cluster production
and mitochondrial function. This, in turn, increases the number
of defective mitochondria at the ER contacts and disturbs
mitochondrial iron, lipid and calcium homeostasis. All these
defects boost ER stress signaling through MAMs leading to
cellular degeneration and cell death.
CONCLUSION
We have demonstrated that Marf downregulation rescues the
locomotion and the accumulation of lipid droplets triggered by
targeted frataxin depletion in glia along with nervous system
degeneration. The analysis of the mechanism underlying such
recovery has allowed us to underscore that alterations in the
ER biology are pivotal in the neurodegeneration in FRDA. Our
results suggest that Marf and ER stress represent a hub in
the neurodegenerative process of FRDA and uncover both as
important elements substantially involved the FRDA pathology.
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FIGURE S1 | Behavioral and mitochondrial defects triggered by frataxin
downregulation in fly muscles. (A) Two independent RNAi lines induce a
frataxin downregulation in thoracic muscles using Mef2-GAL4 from 60%
(fhRNAi-2) to 90% (fhRNAi-1). (B) Targeted frataxin knockdown in muscles was
sufficient to shorten mean and maximum life span. (C) Frataxin silencing in
muscles impairs negative geotaxis already at 3 days after eclosion and
completely abolished locomotion after 5 days upon severe downregulation and
after 15 days upon moderate silencing. (D) Frataxin depletion in the fly
musculature induces hypersensitivity towards oxidative insult. (E) Aconitase
activity is clearly diminished in frataxin-deficient muscles 5 days post eclosion.
(F) ATP production is severely affected in frataxin-deficient flies (50%) and the
age-dependent decay of ATP is enhanced upon frataxin-silencing. (G–J) In
order to analyze individual differences between organelles, we stained the
mitochondria with the permeable dye tetramethylrhodamine, ethyl ester
(TMRE), which only accumulates inside of mitochondria, which are active and
which have a normal membrane potential. (G) TMRE staining of 1-day-old
control muscles. Perfect colocalization between mitoGFP and TMRE signals
indicating functional mitochondria. (H) TMRE staining of 1-day-old Friedreich’s
ataxia (FRDA) muscles. Arrows indicate lack of colocalization between
mitoGFP and TMRE signals in some organelles suggesting impaired
mitochondrial membrane potential already in young flies. (I) TMRE staining of
7-day-old control muscles. Perfect colocalization between mitoGFP and TMRE
signals. (J) TMRE staining of 7-day-old FRDA muscles. No colocalization
between mitoGFP and TMRE signals in most mitochondria indicating that
membrane potential is abolished. (K) Magnification from (J). TMRE staining of
7-day-old FRDA muscles. Arrows denote representative mitochondria in which
TMRE is not incorporated into the organelle due to a deficient membrane
potential indicating severe mitochondrial dysfunction. This is consistent with
the biochemical dysfunctions described in (E,F). (L) Quantification of
mitochondrial TMRE signal in controls and frataxin deficient mitochondria.
Clear reduction of mitochondrial to cytoplasmic ratio in 1-day-old FRDA flies
suggesting a mitochondrial dysfunction already at this age. Age worsened the
phenotype. Scale bars represents 3 µm in (K) and 10 µm in the rest of panels.
Graphs represent means ± SEM. Data were analyzed by Unpaired T-test in
(E,F), by Log-rank (Mantel-Cox) and Gehan-Breslow-Wilcoxon tests in (B,D)
and by one-way ANOVA with post hoc Tukey Multiple Comparison test in
(A,C,L). ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001.
FIGURE S2 | Analysis of age-dependent accumulation of p62-positive vesicles
upon frataxin silencing in fly muscles. (A) MitoGFP labeled mitochondria from
1-day-old controls (UAS-mitoGFP/+; Mef2-GAL4/UAS-mcherryRNAi).
(B) MitoGFP labeled mitochondria from 1-day-old frataxin-deficient thoraces
(UAS-mitoGFP/+; Mef2-GAL4/fhRNAi-1). (C) MitoGFP labeled mitochondria
from 25-day-old controls (UAS-mitoGFP/+; Mef2-GAL4/UAS-mcherryRNAi).
(D) MitoGFP labeled mitochondria from 25-day-old frataxin-deficient thoraces
(UAS-mitoGFP/fhRNAi-2; Mef2-GAL4/+) A second RNAi also induces some
mitochondrial fragmentation but only in old flies. (E–G) Relative expression
levels of genes involved in mitochondrial quality control and dynamics. Our
results showed that Opa1 (involved in fusion) was upregulated and
dynamin-related protein 1 (Drp1) (involved in fission) was clearly
downregulated. Surprisingly, and in contrast to Opa1, Drosophila Mitofusin
(Marf ), a second gene involved in mitochondrial fusion, was slightly
downregulated. In muscles, Marf also seems to behave differently to its
counterparts in fusion and fission of mitochondria. Pink1 expression was
reduced around 50% whereas the expression of parkin, Pink1’s partner in the
activation of mitophagy, was not affected. We also found that the
transcriptional coactivator spargel (Srl) and the transcription factor tfam, both
involved in the biosynthesis of mitochondria, were not altered in the FRDA
muscle cells. Similar results were obtained in old fhRNAi-2 flies. (H–H′′)
Representative pictures of 1600 µm2 from 1 (H), 5 (H′) and 10 (H′′) day-old
frataxin-deficient muscles stained with anti-P62 and used to calculate the
results represented in (I,J). (I) Analysis of size of p62 vesicles in
frataxin-deficient flies at three different time points (1, 5 and 10-day-old flies).
We observed a reduction around 30% after 5 days and 50% after 10 days. This
result is consistent with the increased mitochondrial fragmentation reported in
Figure 3B. (J) Quantification of p62 vesicles in frataxin-deficient flies at 3
different ages (1, 5, 10 days). The number of vesicles increased by 8-fold at 10
days compared to 1 day. (K) mRNA expression levels of Drosophila p62 in
control and frataxin-deficient muscles. p62 expression is only slightly
upregulated in FRDA flies. (L) Magnification from Figure 3D. p62 signals form
vesicular structures that engulf mitochondria as part of the in vivo clearance
process. (M) Quantification of mtDNA content in frataxin-deficient muscles by
semiquantitative Real Time PCR. Clear accumulation of mtDNA in FRDA flies.
The method was validated reproducing the reported content in the Pink1B9
mutant allele. (N–P) Representative confocal pictures from controls (N,
UAS-mitoGFP/+; Mef2-GAL4/UAS-mcherryRNAi), parkin-deficient muscles (O,
UAS-mitoGFP/+; Mef2-GAL4/UAS-parkinRNAi) and pink1-deficient muscles
(P, UAS-mitoGFP/+; Mef2-GAL4/UAS-Pink1RNAi). Mitochondria were labeled
using mitoGFP and mitophagy was monitored with anti-p62. Defects in
mitochondrial morphology could be detected upon parkin and pink1 silencing
(O,P). Interestingly, p62 staining seemed to be enhanced in parkin and pink1
deficient muscles but p62 was not recruited to the enlarged mitochondria
(arrows in O,P). This corroborates that functional parkin or pink1 are required to
recruit p62 into defective mitochondria. (Q–T) Representative confocal pictures
from controls (Q,S, UAS-mitoGFP/+; Mef2-GAL4/UAS-mcherryRNAi) and
frataxin deficient flies using the second RNAi line (R,T,
UAS-mitoGFP/fhRNAi-2; Mef2-GAL4/+). Accumulation of p62 was only
noticeable in old FRDA flies (T). Scale bars represent 10 µm in all except for (L)
that represents 1 µm. All graphs represent means ± SEM. Data was analyzed
by Unpaired T-test in (E,F,G,K,M) and by one-way ANOVA with post hoc
Dunnett Multiple Comparison test in (I,J). ∗P < 0.05; ∗∗P < 0.01;
∗∗∗P < 0.001.
FIGURE S3 | Histological analysis of autophagy markers in control flies.
(A) Representative LAMP1GFP and p62 patterns in the GGCs of a 35-day-old
control fly (UAS-LAMP1GFP/+; Repo-GAL4/UAS-mcherryRNAi). Controls
presented little amounts of LAMP1 and p62 structures, indicative of basal
autophagic levels. (B) Representative LAMP1GFP and p62 patterns in the
GGCs of a 35-day-old FRDA fly (UAS-LAMP1GFP/+; Repo-GAL4/fhRNAi-1).
Increased p62 signals. LAMP1GFP immunoreactivity is enhanced nearby the
p62 vesicles suggesting the formation of autophagolysosomes to degrade
mitochondria. Arrows denote colocalization of LAMP1 and p62 signals.
Unfortunately, the reduced size of organelles in glial cells hampered an
accurate analysis. (C) Representative GFPATG8a and p62 patterns in GGCs of
a 35-day-old control fly (Repo-GAL4/ UAS-GFPATG8a). (D) In glia, besides
some cytoplasmisc localitation, GFPATG8a also displayed a clear nuclear
pattern as it colocalized with the glial-specific transcription factor Repo
(arrows). This nuclear distribution is in agreement with the findings reported for
fly GFPATG8a and mammalian LC3/ATG8 (Mauvezin et al., 2014; Huang et al.,
2015), respectively). This localization is necessary for the deacetylation of
LC3 by Sirt1. Loss of acetyl groups at two specific lysine residues is required
for interaction with ATG7 that triggers the formation of autophagosomes
(Huang et al., 2015). (E) Quantification of GFPATG8a and LAMPGFP western
blots from muscles. Clear increase of Free GFP upon frataxin silencing also in
muscles. This result might suggest increased mitophagic flux in muscles too.
(F) Representative picture of LAMP1GFP and p62 patterns in 5-day-old control
muscles (UAS-LAMP1GFP/+; Mef2-GAL4/UAS-mcherryRNAi).
(G) Representative picture of GFPATG8a and p62 patterns in 5-day-old control
flies (Mef2-GAL4/UAS-GFPATG8a). Scale bars represent 40 µm in (A–D) and
10 µm in (F,G). Graph in (E) represents means ± SEM. Statistical analysis was
performed by Unpaired T-test. ∗P < 0.0; ∗∗∗P < 0.001.
FIGURE S4 | Effects of genetic and chemical induction of autophagy in
frataxin-deficient flies. (A) Representative GFPATG8a and p62 patterns in the
optic lobe of a 35-day-old FRDA fly (fhRNAi-1/+;
Repo-GAL4/UAS-GFPATG8a). Interestingly, no p62 accumulation is detected
in the GGCs region. Arrows denote autophagosomes. (B) Representative
semithin epon plastic section of a 35-day-old frataxin-deficient fly coexpressing
GFPATG8a. Brain vacuolization in the lamina and in the outer chiasm was
significantly reduced. However, GFPATG8a coexpression was not sufficient
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to counteract the accumulation of lipid droplets (arrows), another hallmark of
frataxin-deficiency in Drosophila glia (Navarro et al., 2010). (C) Representative
semithin epon plastic section of a 35-day-old frataxin-deficient fly coexpressing
LAMP1GFP. A strong vacuolization (asterisks) is detected in the lamina and in
the outer chiasm. The presence of lipid accumulation is denoted by droplets
distributed throughout the brain (arrows as example). (D) Quantification of
degenerated area (%) in 35-day-old frataxin-deficient flies expressing
UAS-LAMP1GFP, UAS-GFPATG8a and UAS-ATG8a compared to
coexpression of UAS-GFP analyzed area. Vacuolization was improved upon
expression of ATG8a transgenes. (E) Representative paraffin brain section from
a 35-day-old fly displaying frataxin knockdown and expression of ATG8a in glial
cells (fhRNAi-1/+; Repo-GAL4/UAS-ATG8a). Strong reduction of brain
vacuolization was observed. (F) Representative p62 patterns in the optic lobe
of a 35-day-old FRDA fly coexpressing UAS-ATG8a. No p62 accumulation was
detected in the GGCs region. (G) p62 levels in frataxin-deficient muscles
overexpressing autophagy markers GFPATG8a and LAMP1GFP. Muscles with
increased expression of GFPATG8a showed lower levels of p62 compared to
individuals overexpressing either the lysosomal marker LAMP1GFP or an
unrelated marker (ERGFP). (H) Negative locomotor performance of 5-day-old
controls and flies displaying glial-specific frataxin silencing treated with
rapamycin. (I) Quantification of degenerated area (%) in FRDA flies treated with
rapamycin or with control food (DMSO). Rapamycin was unable to improve the
locomotor deficit and the brain degeneration present in frataxin-deficient flies.
Scale bars represent 50 µm in (B,C,E) and 40 µm in (A,F). All graphs are
represented as means ± SEM. Statistical analysis was performed by one-way
ANOVA with post hoc Dunnett Multiple Comparison test in (D,G,H) and
Unpaired T-test in (I). ∗∗P < 0.01; ∗∗∗P < 0.001.
FIGURE S5 | ER morphology in frataxin-deficient glial cells and muscles.
(A) Representative image of 35-day-old control GGCs (UAS-ERGFP/+;
Repo-GAL4/+) stained with anti-Repo antibody to label cell nuclei. Perinuclear
localization of ER cisternae is observed. (B) Representative image of
35-day-old frataxin-depleted GGCs (UAS-ERGFP/fhRNAi-1; Repo-GAL4/+)
stained with anti-Repo antibody to label cell nuclei. No important alteration of
the ER network was detected. (C) Representative image of 7-day-old control
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